Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis

Accumulating evidence has suggested that farnesoid X receptor (FXR) agonists, such as obeticholic acid (OCA) are therapeutically useful for non-alcoholic steatohepatitis (NASH). However, it is still unclear how FXR agonists protect against NASH and which cell type is the main target of FXR agonists....

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Toshihiro, Itoh, Michiko, Suganami, Takayoshi, Kanai, Sayaka, Shirakawa, Ibuki, Sakai, Takeru, Asakawa, Masahiro, Yoneyama, Toshihiro, Kai, Toshihiro, Ogawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970222/
https://www.ncbi.nlm.nih.gov/pubmed/29802399
http://dx.doi.org/10.1038/s41598-018-26383-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970222/
https://www.ncbi.nlm.nih.gov/pubmed/29802399
http://dx.doi.org/10.1038/s41598-018-26383-8

Ejemplares similares